• News
  • SAN DIEGO
  • Finance

Acadia Pharmaceuticals announces equity financing

Acadia Pharmaceuticals Inc. announced a private placement equity financing and will receive gross proceeds of $86.4 million from the sale of its securities.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Acadia Pharmaceuticals Inc.

Company Website

3911 Sorrento Valley Blvd.
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ACAD
32.84
  1.34  
+ 4.25%
1,337,684,000
33.43
15.64

Insider Trade Data

Date Insider Shares Type Value
12/09/2014 Baity, Glenn F 8,000 Exchange $12,400
12/09/2014 Baity, Glenn F 8,000 Exchange $12,400
11/26/2014 Mills, Roger G 25,000 Exchange $38,750
11/26/2014 Mills, Roger G 25,000 Sell $752,265
11/26/2014 Borer, Michael T 15,000 Exchange $165,000

Acadia Pharmaceuticals Inc. Executive(s):

Uli Hacksell

  • Chief Executive Officer, President

Similar Companies

NAICS - 325412 - Pharmaceutical Preparation Manufacturing
SIC - 2834 - PHARMACEUTICAL PREPARATIONS
SIC - 2835 - IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES
NAICS - 541711 - Research and Development in Biotechnology
SIC - 8731 - COMMERCIAL PHYSICAL AND BIOLOGICAL RESEARCH
SIC - 8733 - NONCOMMERCIAL RESEARCH ORGANIZATIONS
Subscribe Today!